
Psychedelic Research Proves Rather Tricky for the FDA
Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.

Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.

As Arizona lawmakers fight to extend psilocybin research deadlines, bipartisan leaders have introduced new legislation that would legalize psilocybin service centers in the state.

A proposed bill offered up by a Republican lawmaker in Indiana would open the door for the state to research psilocybin, the psychedelic compound in “magic mushrooms.”

Congress has passed a defense spending bill that includes $10 million to fund research into psychedelics to treat active duty service members with traumatic brain injuries or PTSD.

Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.

As Arizona lawmakers fight to extend psilocybin research deadlines, bipartisan leaders have introduced new legislation that would legalize psilocybin service centers in the state.

A proposed bill offered up by a Republican lawmaker in Indiana would open the door for the state to research psilocybin, the psychedelic compound in “magic mushrooms.”

Congress has passed a defense spending bill that includes $10 million to fund research into psychedelics to treat active duty service members with traumatic brain injuries or PTSD.
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!
